LinkedIn
icn_podcast Podcasts
View All Upcoming Courses
Specialty
Course Type
Search
Login
Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Optometry Retina Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login
Menu

Treating Presbyopia: New Approaches to a Familiar Problem

By: Francis S. Mah, MD (Chair); Marguerite McDonald, MD, FACS; George O. Waring IV, MD, FACS

Begin Course

This course has expired. You can still review the content but course credit is no longer available.

Supplement Credits: 1

Content Source

This continuing medical education (CE/CME) activity captures content from a live symposium at ASCRS.

Activity Description

Based on a live symposium held during the American Society for Cataract and Refractive Surgeons Annual Meeting, this supplement summarizes the presentations on how to manage presbyopic changes with a variety of current and newly emerging treatment options, and how strategies may work synergistically.

Target Audience

This certified continuing medical education activity is designed for ophthalmologists and optometrists involved in the care of patients with presbyopia.

Expiration Date: Sunday, November 5, 2023
Release Date: November 5, 2021

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Differentiate the underlying mechanisms of presbyopic changes.
  • Interpret the clinical trial experience published in the literature with pharmaceutical and nonpharmaceutical presbyopia-correcting options.
  • Distinguish among the pharmacological properties of newly emerging presbyopia-correcting drops and their mechanisms of action.
  • Explain how presbyopia-correcting drops are likely to affect categories of patients based on individual characteristics.
  • Describe the side effects of pharmaceutical approaches to presbyopia correction with other treatment options to debate the pros and cons of each strategy.

Accreditation and Designation Statement

This educational activity is provided by Evolve Medical Education LLC (Evolve).

Accreditation Statement
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Sponsored by

Evolve Medical Education LLC (Evolve) is an approved COPE administrator.

This activity, COPE Activity Number 122849, is accredited by COPE for continuing education for optometrists. 
This course is approved for 1 hour of CE. 

Course #: 75402-AS
Activity #: 122849

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

Francis S. Mah, MD (Chair)

Director of Corneal and External Disease
Co-Director of Refractive Surgery
Scripps Clinic

La Jolla, CA
 

Marguerite McDonald, MD, FACS

Clinical Professor of Ophthalmology
NYU Langone Medical Center
New York, New York
Clinical Professor of Ophthalmology
Tulane University Health Sciences Center
New Orleans, Louisiana
OCLI Vision
Oceanside, NY

George O. Waring IV, MD, FACS

Founder and Medical Director
Waring Vision Institute
Mount Pleasant, SC

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Francis S. Mah, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Eyenovia, Glaukos, iView, Johnson & Johnson Vision, Nevakar, Novartis, Ocular Science, and RxSight. 

Marguerite McDonald, MD, FACS, has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Blephex, Johnson & Johnson Vision, NTK Enterprises, Orca Surgical, Ocusoft, Oculus USA, Quidel, Stroma, Sun Pharma Industries, TearLab, Tissue Tech, and VISUS. Stock/Shareholder: Ocuphire and RxSight.

George O. Waring IV, MD, FACS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan and Johnson & Johnson.

The Evolve staff and planners have no financial relationships with commercial interests. Scott Krzywonos, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract & Refractive Surgery Today, Modern Optometry, or AbbVie.

Begin Course